EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action?

被引：14
|
作者：
Bugianesi, Elisabetta [1 ]
机构：
[1] Univ Turin, Dept Med Sci, Div Gastroenterol, AOU Citta Salute & Sci, Corso Dogliotti 14, I-10126 Turin, Italy
来源：
DIABETOLOGIA | 2016年 / 59卷 / 06期
关键词：
Cost-effectiveness; Fatty liver; Guidelines; Screening; NAFLD;
D O I：
10.1007/s00125-016-3930-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1145 / 1147
页数：3
相关论文
共 50 条
  • [21] EASL-EASD-EASO Clinical Practice Guidelines on the Man-agement of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (vol 17, pg 374, 2024)
    不详
    OBESITY FACTS, 2024,
  • [22] Should the new EASL-EASD-EASO Clinical Practice Guidelines on MASLD recommend pioglitazone as a MASH-targeted pharmacotherapy?
    Silva Jr, Wellington S.
    Sposito, Andrei C.
    Godoy-Matos, Amelio
    JOURNAL OF HEPATOLOGY, 2025, 82 (01) : e21 - e22
  • [23] EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease
    Mathurin, Philippe
    Hadengue, Antoine
    Bataller, Ramon
    Addolorato, Giovanni
    Burra, Patrizia
    Burt, Alastair
    Caballeria, Juan
    Cortez-Pinto, Helena
    Day, Chris P.
    Forrest, Ewan H.
    Gual, Antoni
    Leon, David A.
    Lligona, Anna
    Jepsen, Peter
    Mueller, Sebastian
    Pageaux, Georges-Philippe
    Roskams, Tania
    Seitz, Helmut K.
    Stickel, Felix
    Thursz, Mark
    Naveau, Sylvie
    Morgan, Tim
    Nevens, Frederik
    JOURNAL OF HEPATOLOGY, 2012, 57 (02) : 399 - 420
  • [24] European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes
    Sberna, A. L.
    Bouillet, B.
    Rouland, A.
    Brindisi, M. C.
    Nguyen, A.
    Mouillot, T.
    Duvillard, L.
    Denimal, D.
    Loffroy, R.
    Verges, B.
    Hillon, P.
    Petit, J. M.
    DIABETIC MEDICINE, 2018, 35 (03) : 368 - 375
  • [25] Clinical guidelines of non-alcoholic fatty liver disease: A systematic review
    Jin-Zhou Zhu
    Kelseanna Hollis-Hansen
    Xing-Yong Wan
    Su-Juan Fei
    Xun-Lei Pang
    Fan-Dong Meng
    Chao-Hui Yu
    You-Ming Li
    World Journal of Gastroenterology, 2016, 22 (36) : 8226 - 8233
  • [26] Clinical guidelines of non-alcoholic fatty liver disease: A systematic review
    Zhu, Jin-Zhou
    Hollis-Hansen, Kelseanna
    Wan, Xing-Yong
    Fei, Su-Juan
    Pang, Xun-Lei
    Meng, Fan-Dong
    Yu, Chao-Hui
    Li, You-Ming
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (36) : 8226 - 8233
  • [27] Management of non-alcoholic fatty liver disease
    Lanuza, Fabian
    Sapunar, Jorge
    Hofmann, Edmundo
    REVISTA MEDICA DE CHILE, 2018, 146 (08) : 894 - 901
  • [28] Management of non-alcoholic fatty liver disease
    Petroni, Maria Letizia
    Brodosi, Lucia
    Bugianesi, Elisabetta
    Marchesini, Giulio
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
  • [29] EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary (Jun 13, 10.1007/s00125-024-06196-3, 2024)
    Tacke, Frank
    Horn, Paul
    Wong, Vincent Wai-Sun
    Ratziu, Vlad
    Bugianesi, Elisabetta
    Francque, Sven
    Zelber-Sagi, Shira
    Valenti, Luca
    Roden, Michael
    Schick, Fritz
    Yki-Jarvinen, Hannele
    Gastaldelli, Amalia
    Vettor, Roberto
    Fruhbeck, Gema
    Dicker, Dror
    DIABETOLOGIA, 2024, 67 (11) : 2608 - 2608
  • [30] Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
    Alejandro Campos-Murguía
    Astrid Ruiz-Margáin
    José A González-Regueiro
    Ricardo U Macías-Rodríguez
    World Journal of Gastroenterology, 2020, (39) : 5919 - 5943
12345